trial · primary record
Bevacizumab
Diabetic Macular Edema (DME)
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 60 |
| Primary completion | 2027-12 |
| Primary endpoint | Central Macular Thickness |
| Registry ID | NCT07897630 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:31:54.370Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07897630
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.